News Image

Thursday's session: top gainers and losers

By Mill Chart

Last update: Sep 29, 2022

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.

Top gainers

TickerChangeComment
SNTI45.01%SENTI BIOSCIENCES INC's (NASDAQ:SNTI) stock price increased by 45.01% to $2.03. Shareholders saw the stock price going 27.08% lower in the past month.
BBAI33.71%BIGBEAR.AI HOLDINGS INC's (NYSE:BBAI) stock price is advancing with 33.71% to a price of $1.59. Earlier today the company had a press release: BigBear.ai Awarded $14.8 Million U.S. Army Global Force Information Management System Contract.
AVCTW22.67%PENSARE ACQUISITION CORP-CW (NASDAQ:AVCTW) rose 22.67% to $0.06 during Thursday's after hours session. In the last 3 months the share price increased with 41.13%.
JUPW20.59%JUPITER WELLNESS INC's (NASDAQ:JUPW) shares rose 20.59% to $0.73 during Thursday's session. In the last month the share price dropped with 21.68%.
AVCO19.68%AVALON GLOBOCARE CORP's (NASDAQ:AVCO) stock price increased by 19.68% to $0.67. In the last 6 months the stock lost 21.17%.
SSNT18.15%SILVERSUN TECHNOLOGIES INC (NASDAQ:SSNT) rose 18.15% to $2.93 during Thursday's after hours session. A press release (SSNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of SilverSun Technologies, Inc. Is Fair to Shareholders) was released earlier today.
INDO17.97%INDONESIA ENERGY CORP LTD's (NYSEARCA:INDO) stock price is advancing with 17.97% to a price of $7.22. The stock is trading 71.42% lower than 6 months ago.
SBIG17.28%SPRINGBIG HOLDINGS INC's (NASDAQ:SBIG) stock price increased by 17.28% to $0.95. Shareholders saw the stock price going 46.71% lower in the past month.
IMVT17.22%IMMUNOVANT INC (NASDAQ:IMVT) rose 17.22% to $5.62 during Thursday's after hours session. In the last 3 months the stock gained 20.35%.
AUST15.46%AUSTIN GOLD CORP's (NYSEARCA:AUST) stock price is advancing with 15.46% to a price of $1.12. In the last month the stock lost 38.61%.

Our top gainers screener will show you the full list.

Losers

TickerChangeComment
SUNL-59.92%SUNLIGHT FINANCIAL HOLDINGS's (NYSE:SUNL) stock price is declining with 59.92% to a price of $1.01. Yesterday the company had a press release: Sunlight Financial Announces Impact to Full-Year 2022 Outlook.
LGHL-49.25%LION GROUP HOLDING LTD-S ADR's (NASDAQ:LGHL) shares fell 49.25% to $1.01 during Thursday's session. Shareholders saw the stock price going 125.0% higher in the past 3 months.
ADVWW-44.05%ADVANTAGE SOLUTIONS IN-CW25's (NASDAQ:ADVWW) stock price is declining with 44.05% to a price of $0.12. In the last month the stock lost 52.28%.
SOBR-29.96%SOBR SAFE INC's (NASDAQ:SOBR) stock price decreased by 29.96% to $1.73. A press release (SOBR Safe Technology Is Doing More Than Generating Revenues And Creating Shareholder Value; It’s Saving Lives ($SOBR)) was released yesterday.
PHAS-29.53%PHASEBIO PHARMACEUTICALS INC's (NASDAQ:PHAS) shares fell 29.53% to $0.18 during Thursday's session. Shareholders saw the stock price going 75.29% lower in the past month.
ML-27.84%MONEYLION INC's (NYSE:ML) shares fell 27.84% to $0.82 during Thursday's session. In the last month the share price dropped with 25.0%.
VEEE-27.61%TWIN VEE POWERCATS CO's (NASDAQ:VEEE) shares fell 27.61% to $2.57. Shareholders saw the stock price going 22.32% lower in the past month.
RAD-27.38%RITE AID CORP's (NYSE:RAD) stock price decreased by 27.38% to $5.11. The company's earnings where released Yesterday. A press release (Rite Aid Corporation Reports Fiscal 2023 Second Quarter Results) was released yesterday.
ISR-26.67%ISORAY INC's (NYSEARCA:ISR) stock price decreased by 26.67% to $0.22. A press release (ISR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Isoray, Inc. Is Fair to Shareholders) was released earlier today.
PT-23.92%PINTEC TECHNOLOGY HOLDINGS L's (NASDAQ:PT) stock price decreased by 23.92% to $0.3. In the last month the share price dropped with 62.21%.

Our top losers screener will show you the full list.

Back

SENTI BIOSCIENCES INC

NASDAQ:SNTI (4/17/2024, 7:25:51 PM)

After market: 0.31 0 (0%)

0.31

+0.01 (+3.33%)

SNTI News

News Imagea month ago - InvestorPlaceSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Senti Biosciences (NASDAQ:SNTI) just reported results for the fourth quarter of...

News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

– IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second...

News Image3 months ago - Seeking AlphaSenti Biosciences to reduce workforce by 37% (NASDAQ:SNTI)

Senti Biosciences plans to cut workforce by ~37% to prioritize investment in its cell therapy for acute myeloid leukemia, SENTI-202.

News Image3 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
News Image3 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1...

News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability...

News Image4 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!

SNTI Links
Follow us for more